Efficacy and safety of long-term RN-1 treatment to increase HbF in baboons.
作者信息
Ibanez Vinzon, Vaitkus Kestis, Rivers Angela, Molokie Robert, Cui Shuaiying, Engel James Douglas, DeSimone Joseph, Lavelle Donald
机构信息
Department of Medicine, University of Illinois at Chicago, Chicago, IL.
Jesse Brown Veterans Affairs Medical Center, Chicago, IL.
出版信息
Blood. 2017 Jan 12;129(2):260-263. doi: 10.1182/blood-2016-10-746727. Epub 2016 Dec 1.
Abstract
摘要
相似文献
1
Efficacy and safety of long-term RN-1 treatment to increase HbF in baboons.
Blood. 2017 Jan 12;129(2):260-263. doi: 10.1182/blood-2016-10-746727. Epub 2016 Dec 1.
2
The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice.
Blood. 2015 Jul 16;126(3):386-96. doi: 10.1182/blood-2015-02-626259. Epub 2015 Jun 1.
3
Oral administration of the LSD1 inhibitor ORY-3001 increases fetal hemoglobin in sickle cell mice and baboons.
Exp Hematol. 2018 Nov;67:60-64.e2. doi: 10.1016/j.exphem.2018.08.003. Epub 2018 Aug 17.
4
Potential role of LSD1 inhibitors in the treatment of sickle cell disease: a review of preclinical animal model data.
Am J Physiol Regul Integr Comp Physiol. 2018 Oct 1;315(4):R840-R847. doi: 10.1152/ajpregu.00440.2017. Epub 2018 Aug 1.
5
RN-1, a potent and selective lysine-specific demethylase 1 inhibitor, increases γ-globin expression, F reticulocytes, and F cells in a sickle cell disease mouse model.
Exp Hematol. 2015 Jul;43(7):546-53.e1-3. doi: 10.1016/j.exphem.2015.04.005. Epub 2015 Apr 27.
6
The LSD1 inhibitor RN-1 recapitulates the fetal pattern of hemoglobin synthesis in baboons (P. anubis).
Haematologica. 2016 Jun;101(6):688-97. doi: 10.3324/haematol.2015.140749. Epub 2016 Feb 8.
7
Inhibition of LSD1 by small molecule inhibitors stimulates fetal hemoglobin synthesis.
Blood. 2019 May 30;133(22):2455-2459. doi: 10.1182/blood.2018892737. Epub 2019 Apr 16.
8
Effect of the LSD1 inhibitor RN-1 on γ-globin and global gene expression during erythroid differentiation in baboons (Papio anubis).
PLoS One. 2023 Dec 22;18(12):e0289860. doi: 10.1371/journal.pone.0289860. eCollection 2023.
9
Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell disease.
Exp Hematol. 2017 Jun;50:46-52. doi: 10.1016/j.exphem.2017.02.003. Epub 2017 Feb 24.
10
Pulsed-dosing with oral sodium phenylbutyrate increases hemoglobin F in a patient with sickle cell anemia.
Pediatr Blood Cancer. 2008 Feb;50(2):357-9. doi: 10.1002/pbc.21104.
引用本文的文献
1
Effect of the LSD1 inhibitor RN-1 on γ-globin and global gene expression during erythroid differentiation in baboons (Papio anubis).
PLoS One. 2023 Dec 22;18(12):e0289860. doi: 10.1371/journal.pone.0289860. eCollection 2023.
2
Combinatorial targeting of epigenome-modifying enzymes with decitabine and RN-1 synergistically increases HbF.
Blood Adv. 2023 Aug 8;7(15):3891-3902. doi: 10.1182/bloodadvances.2022009558.
3
Epigenetic plasticity of erythroid progenitors.
Blood. 2021 Nov 4;138(18):1646-1648. doi: 10.1182/blood.2021013087.
4
An erythroid-to-myeloid cell fate conversion is elicited by LSD1 inactivation.
Blood. 2021 Nov 4;138(18):1691-1704. doi: 10.1182/blood.2021011682.
5
Epigenetic regulation of hemoglobin switching in non-human primates.
Semin Hematol. 2021 Jan;58(1):10-14. doi: 10.1053/j.seminhematol.2020.12.001. Epub 2020 Dec 28.
6
Modulation of KDM1A with vafidemstat rescues memory deficit and behavioral alterations.
PLoS One. 2020 May 29;15(5):e0233468. doi: 10.1371/journal.pone.0233468. eCollection 2020.
7
Small molecule therapeutics to treat the β-globinopathies.
Curr Opin Hematol. 2020 May;27(3):129-140. doi: 10.1097/MOH.0000000000000579.
8
Oral administration of the LSD1 inhibitor ORY-3001 increases fetal hemoglobin in sickle cell mice and baboons.
Exp Hematol. 2018 Nov;67:60-64.e2. doi: 10.1016/j.exphem.2018.08.003. Epub 2018 Aug 17.
9
Potential role of LSD1 inhibitors in the treatment of sickle cell disease: a review of preclinical animal model data.
Am J Physiol Regul Integr Comp Physiol. 2018 Oct 1;315(4):R840-R847. doi: 10.1152/ajpregu.00440.2017. Epub 2018 Aug 1.
10
Targeting histone methyltransferase and demethylase in acute myeloid leukemia therapy.
Onco Targets Ther. 2017 Dec 28;11:131-155. doi: 10.2147/OTT.S145971. eCollection 2018.
本文引用的文献
1
The LSD1 inhibitor RN-1 recapitulates the fetal pattern of hemoglobin synthesis in baboons (P. anubis).
Haematologica. 2016 Jun;101(6):688-97. doi: 10.3324/haematol.2015.140749. Epub 2016 Feb 8.
2
KDM1 histone lysine demethylases as targets for treatments of oncological and neurodegenerative disease.
Epigenomics. 2015;7(4):609-26. doi: 10.2217/epi.15.9.
3
The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice.
Blood. 2015 Jul 16;126(3):386-96. doi: 10.1182/blood-2015-02-626259. Epub 2015 Jun 1.
4
RN-1, a potent and selective lysine-specific demethylase 1 inhibitor, increases γ-globin expression, F reticulocytes, and F cells in a sickle cell disease mouse model.
Exp Hematol. 2015 Jul;43(7):546-53.e1-3. doi: 10.1016/j.exphem.2015.04.005. Epub 2015 Apr 27.
5
Prasugrel in children with sickle cell disease: pharmacokinetic and pharmacodynamic data from an open-label, adaptive-design, dose-ranging study.
J Pediatr Hematol Oncol. 2015 Jan;37(1):1-9. doi: 10.1097/MPH.0000000000000291.
6
Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A.
Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):6518-23. doi: 10.1073/pnas.1303976110. Epub 2013 Apr 1.
7
Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction.
Nat Med. 2013 Mar;19(3):291-4. doi: 10.1038/nm.3101. Epub 2013 Feb 17.
8
Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation.
Leukemia. 2012 Sep;26(9):2039-51. doi: 10.1038/leu.2012.157. Epub 2012 Jun 13.
9
Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabine.
Blood. 2012 Feb 2;119(5):1240-7. doi: 10.1182/blood-2011-08-371690. Epub 2011 Dec 7.
10
Nuclear receptors TR2 and TR4 recruit multiple epigenetic transcriptional corepressors that associate specifically with the embryonic β-type globin promoters in differentiated adult erythroid cells.
Mol Cell Biol. 2011 Aug;31(16):3298-311. doi: 10.1128/MCB.05310-11. Epub 2011 Jun 13.
Zotero 插件